FierceHealthcareFierceHealthITFierceHealthFinanceHospital Impact   FiercePharmaFierceBiotechFierceSarbox
Syndicate content

Vytorin news from FierceHealthcare

Most Popular Vytorin story
Related Tags pharmaceutical companies   Merck   Vioxx   Food and Drug Administration (FDA)
Tools

News

Trend: Providers increase use of CT scans

July 1, 2008 — 2:04am ET | By Anne Zieger
To date, CT scans have never been proved in large medical studies to be better than other forms of imaging. Worse, they expose patients to larger doses of radiation than other scans, equivalent to... Read more...

Drugmakers agree to six-month DTC delay

June 17, 2008 — 11:18am ET | By Anne Zieger
Under fire over direct-to-consumer ads, which some Congressional legislators contend are misleading to consumers, pharmaceutical companies have agreed to voluntarily wait six months after drugs are... Read more...

ALSO NOTED: Demand for health IT pros to soar; Pharmas lobbying hard in DC; and much more...

April 21, 2008 — 6:59am ET
> Industry researchers are predicting that it will take a huge increase in the volume of professionals available (more than 40,000) to meet the near-term demand for skilled health IT pros. Read more...

Reports suggest that Merck downplayed Vioxx risks

April 16, 2008 — 6:59am ET
Another day, another report suggesting that a pharmaceutical company tried to bury data impugning the safety of one of its products. This time, a study has been published in The Journal of the... Read more...

FDA says Glaxo didn't report Avandia data

April 9, 2008 — 6:59am ET
According to a new letter from the agency, GlaxoSmithKline didn't turn over post-marketing data about Avandia to the FDA, a lack of disclosure that looks pretty unfortunate given subsequent reports... Read more...

ALSO NOTED: UnitedHealth stands behind Vytorin; Groups release diabetes management toolkit; and much more...

April 4, 2008 — 7:59am ET
> Despite the controversy over its effectiveness, UnitedHealth Group has said that it will continue to cover Vytorin has it has in the past. Read more...

Congress says drugmakers held back Vytorin data

April 1, 2008 — 7:59am ET
Cholesterol drug Vytorin--and makers Merck and Schering-Plough--have been under fire for months since a study suggested that the expensive combo med works no better than much less costly Zocor.... Read more...

Get more Vytorin coverage at:

FierceHealthIT